InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.33 USD
↘ 0.02 (1.48%)AT CLOSE (03:59 PM EDT)
1.33
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.33
↗ 0.00 (0.00%)
🔴Market: CLOSED

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.33. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place INM at a fair price relative to peers.

Technical & fundamental data as of Oct 2, 2026.

Open?$1.37
High?$1.39
Low?$1.33
Prev. Close?$1.35
Volume?28.3K
Avg. Volume?71.1K
VWAP?$1.35
Rel. Volume?0.40x
Bid / Ask
Bid?$1.15 × 100
Ask?$1.54 × 100
Spread?$0.39
Midpoint?$1.35
Valuation & Ratios
Market Cap?7.3M
Shares Out?5.5M
Float?3.3M
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?6.80
EPS?-$2.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
6
Market Cap
7.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
C/O NORTON ROSE FULBRIGHT CANADA LLP
VANCOUVER, V6B 0M3
Phone: (604) 669-7207
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-67.75Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.48%Low
Short Interest?15.9K
Days to Cover?1.0
Free Float3.3M
Avg Daily Volume44.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.45Adequate
Quick Ratio?1.45Adequate
Cash Ratio?1.19Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
27
6.80FAIR▾
P/S?
Peers
100
S&P
40
3.77FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
66
2.63CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-1,208.6%WEAK▾
ROA?
S&P
3
-428.8%WEAK▾
Cash Flow & Enterprise
FCF?$-8643513
Enterprise Value?$5.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist